HDL Is Not Always Good Cholesterol During Menopause Transition
Data from the large-scale SWAN study suggest a rethinking of HDL as beneficial cholesterol for women in menopause.
Data from the large-scale SWAN study suggest a rethinking of HDL as beneficial cholesterol for women in menopause.
Nocebo/drucebo effect should be considered when statins are first prescribed; personalized lipid intervention plan should be provided
Three-quarters of all psychiatric disorders occur by early adulthood (mid-20s). This fact suggests that bio-psychosocial factors occurring from the fetal period through early adulthood could play a crucial role in risk. This nonsystematic review sought to synthesize key epidemiological evidence of relevant risk factors.
Intermittent fasting has demonstrated health benefits in a number of randomized clinical trials. Researchers sough to directly link specific health outcomes from these trials in people with overweight or obesity.
Author describes efficacy and safety information on red yeast rice in the treatment of dyslipidemia.
A team of researchers investigated the relationship between bipolar disorder and major adverse cardiac events.
A network meta-analysis was done to compare the effectiveness of SGLT2 inhibitors in participants with type 2 diabetes and cardiovascular risk factors.
Laparoscopic sleeve gastrectomy led to a statistically significant reduction in epicardial fat thickness, a marker for atherosclerosis, 12 months after surgery.
One of the researchers’ goals was to investigate the association between newly detected disturbances of glucose metabolism and long-term prognosis after AMI.
SGLT2i use was linked to reduced mortality and morbidity in a real-world cohort of patients with heart failure and diabetes.